The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU Hematology & Medical Oncology Review 2019
W

Anti-PD-1 Therapy and Dose Modification in Advanced Gastroesophageal Cancers: How Much Do We Know?

By KU Hematology & Medical Oncology Review 2019 FEATURING Weijing Sun
By KU Hematology & Medical Oncology Review 2019 FEATURING Weijing Sun
313 views
August 23, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
Gastrointestinal
14:39
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Updates on Pancreatic Cancer: Maintenance Olaparib and …

Feat. R. Al-Rajabi
16:20
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Updates on Hepatobiliary Cancer: Pembrolizumab vs. Best…

Feat. R. Al-Rajabi
19:12
KU Hematology & Medical Oncology Review 2019

Management of Toxicities in Neoadjuvant (Perioperative) Chemotherapy…

Feat. W. Sun
18:29
KU Hematology & Medical Oncology Review 2019

Anti-PD-1 Therapy and Dose Modification in Advanced Gastroesophageal…

Feat. W. Sun